155 related articles for article (PubMed ID: 34890645)
1. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
Gehring K; Kozlov G; Yang M; Fakih R
J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
[TBL] [Abstract][Full Text] [Related]
2. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
Fakih R; Goldstein RH; Kozlov G; Gehring K
J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
[TBL] [Abstract][Full Text] [Related]
3. PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
Kozlov G; Funato Y; Chen YS; Zhang Z; Illes K; Miki H; Gehring K
J Biol Chem; 2020 Aug; 295(33):11682-11692. PubMed ID: 32571875
[TBL] [Abstract][Full Text] [Related]
4. Phosphocysteine in the PRL-CNNM pathway mediates magnesium homeostasis.
Gulerez I; Funato Y; Wu H; Yang M; Kozlov G; Miki H; Gehring K
EMBO Rep; 2016 Dec; 17(12):1890-1900. PubMed ID: 27856537
[TBL] [Abstract][Full Text] [Related]
5. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
6. PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3.
Zhang H; Kozlov G; Li X; Wu H; Gulerez I; Gehring K
Sci Rep; 2017 Mar; 7(1):48. PubMed ID: 28246390
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
[TBL] [Abstract][Full Text] [Related]
8. Physiological and oncogenic roles of the PRL phosphatases.
Hardy S; Kostantin E; Hatzihristidis T; Zolotarov Y; Uetani N; Tremblay ML
FEBS J; 2018 Nov; 285(21):3886-3908. PubMed ID: 29770564
[TBL] [Abstract][Full Text] [Related]
9. Targeting PRL phosphatases in hematological malignancies.
Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity.
Gehring K; Miki H
Br J Cancer; 2021 Mar; 124(6):1035-1036. PubMed ID: 33268817
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
[TBL] [Abstract][Full Text] [Related]
12. Phosphatase-independent role of phosphatase of regenerating liver in cancer progression.
Funato Y; Hashizume O; Miki H
Cancer Sci; 2023 Jan; 114(1):25-33. PubMed ID: 36285487
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of the PRL phosphatases.
Rios P; Li X; Köhn M
FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
[TBL] [Abstract][Full Text] [Related]
14. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
[TBL] [Abstract][Full Text] [Related]
15. Effect of Pharmacological Inhibition of the Catalytic Activity of Phosphatases of Regenerating Liver in Early T Cell Receptor Signaling Dynamics and IL-2 Production.
Aguilar-Sopeña O; Hernández-Pérez S; Alegre-Gómez S; Castro-Sánchez P; Iglesias-Ceacero A; Lazo JS; Roda-Navarro P
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260565
[TBL] [Abstract][Full Text] [Related]
16. Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism.
Abdollahi P; Vandsemb EN; Børset M
Curr Opin Clin Nutr Metab Care; 2022 Jan; 25(1):50-55. PubMed ID: 34725313
[TBL] [Abstract][Full Text] [Related]
17. Phosphatase and Pseudo-Phosphatase Functions of Phosphatase of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals In Vitro.
Jolly JT; Cheatham TC; Blackburn JS
ACS Omega; 2023 Aug; 8(33):30578-30589. PubMed ID: 37636930
[TBL] [Abstract][Full Text] [Related]
18. PRL phosphatases as potential molecular targets in cancer.
Stephens BJ; Han H; Gokhale V; Von Hoff DD
Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase of regenerating liver: a novel target for cancer therapy.
Campbell AM; Zhang ZY
Expert Opin Ther Targets; 2014 May; 18(5):555-69. PubMed ID: 24579927
[TBL] [Abstract][Full Text] [Related]
20. PRL PTPs: mediators and markers of cancer progression.
Bessette DC; Qiu D; Pallen CJ
Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
